companies developing glp-1 drugs Chinese Are Advanced Covering GLP-1 Drugs: Employers' Top

WARNING: Risk of Thyroid C-Cell Tumors In animal studies, GLP-1 receptor agonists have been associated with thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)

doi: 10.1111/dom.12981

RECOMMENDATIONS Expand Access for GLP-1 Therapies Reform the Patent System: The patent system has been infected by the financialized business model of the pharmaceutical industry

Its important to speak to your healthcare provider about any concerns or adverse reactions while using Saxenda

Ongoing and future largescale randomized trials will be critical for clarifying efficacy and safety for this use

9 The scope of this opinion paper is limited to GLP-1RA therapy and other antidiabetic agents with CV benefits are excluded